e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
The spectrum of approaches to molecular and cellular lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of poly(ADP-ribose) polymerase-1 and its inhibitor in ventilator-induced lung injury
J. H. Kim, G. Y. Hur, S. Y. Lee, S. Y. Lee, C. Shin, J. J. Shim, K. H. In, S. H. Yoo, K. H. Kang (Seoul, South Korea)
Source:
Annual Congress 2004 - The spectrum of approaches to molecular and cellular lung injury
Session:
The spectrum of approaches to molecular and cellular lung injury
Session type:
Thematic Poster Session
Number:
3450
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. H. Kim, G. Y. Hur, S. Y. Lee, S. Y. Lee, C. Shin, J. J. Shim, K. H. In, S. H. Yoo, K. H. Kang (Seoul, South Korea). Role of poly(ADP-ribose) polymerase-1 and its inhibitor in ventilator-induced lung injury. Eur Respir J 2004; 24: Suppl. 48, 3450
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of matrix metalloproteinase inhibitor on ventilator-induced lung injury in rats
Source: Eur Respir J 2002; 20: Suppl. 38, 486s
Year: 2002
Lack of poly(ADP-ribose) polymerase-1 does not affect acute lung injury but induces excessive lung remodelling after hyperoxia exposure
Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Year: 2005
Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
Protective role of PARP inhibitors in reperfusion/reoxygenation injury
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001
Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
The effects of tpl2 inhibition in Ventilator-induced lung injury
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin
Source: Eur Respir J 2008; 31: 363-371
Year: 2008
Inhaled activated protein C protects mice from ventilator-induced lung injury
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
Prevention of ventilator-induced lung injury (VILI)
Source: International Congress 2014 – Acute respiratory distress syndrome (ARDS): the role of prevention
Year: 2014
The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Prophylactic neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014
PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
The role of pendrin in acute lung injury caused by ventilator-induced lung injury
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
The effects of simvastatin in ventilator-induced lung injury
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Sirtuins inhibition modulates endotoxin-induced lung inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
Effects of phosphodiesterase inhibitors on the lung functions in a saline lavage-induced model of acute lung injury
Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents
Year: 2017
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury
Source: Eur Respir J 2003; 22: 20-27
Year: 2003
Role of eNOS in ischemia/reperfusion-induced lung injury
Source: Eur Respir J 2007; 30: Suppl. 51, 293s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept